Evidence map›Paper›PMID 38023952›Full record

ArticleGerms2023

Enterobacteriaceae isolates from clinical and household tap water samples: antibiotic resistance, screening for extended-spectrum, metallo- and ampC-beta-lactamases, and detection of

Olajide J Akinjogunla, Adebowale T Odeyemi, Edinam-Abasi S Udofia, Oyetayo O Adefiranye, Clarence S Yah, Igbagbo Ehinmore, Idongesit U Etukudo

Open access · greenAbstract read
In one paragraph

Article in Germs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Olajide J AkinjogunlaDepartment of Microbiology, Faculty of Science, University of Uyo, P.M.B. 1017, Uyo, Akwa Ibom State, Nigeria.
Adebowale T OdeyemiDepartment of Microbiology, College of Pure and Applied Science, Landmark University, Omu-Aran, Kwara State, Nigeria.
Edinam-Abasi S UdofiaDepartment of Microbiology, Faculty of Science, University of Uyo, P.M.B. 1017, Uyo, Akwa Ibom State, Nigeria.
Oyetayo O AdefiranyeDepartment of Microbiology, University of Lagos, Akoka, Lagos State, Nigeria.
Clarence S YahSchool of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, South Africa.
Igbagbo EhinmoreDepartment of Biological Sciences, Lagos State University of Science and Technology, Ikorodu, Lagos State, Nigeria.
Idongesit U EtukudoDepartment of Microbiology, Abia State University, Uturu, Abia State, Nigeria.
University of Uyo · NGAbia State University · NGLagos State University · NGUniversity of Lagos · NGUniversity of Pretoria · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Infections caused by multidrug-resistant (MDR) bacteria, extended spectrum β-lactamase (ESBL), metallo-β-lactamase (MBL) and AmpC-β-lactamase (AmpC-βL)-producers are increasing globally. This study identified bacteria in clinical and tap water samples and determined the prevalence of MDR, and β-lactamase enzymes and genes. Methods: Isolates were identified by the Vitek 2 (bioMérieux, France) automated system. Antibiotic resistance and screening for β-lactamase enzymes and genes was done using disc diffusion method and Vitek 2 automated system, CHROMagar-ESBL, combined double disc, inhibition-based method and multiplex polymerase chain reaction, respectively. Results: The Enterobacteriaceae isolates obtained were Conclusions: This study found a high prevalence of β-lactamase producers, indicating the need for further research on the molecular epidemiology of β-lactamase producers and their impacts in the region.

Indexed as

betalactamaseEnterobacteriaceaemultidrugprevalenceresistance

Identifiers

PMID38023952
PMCPMC10659753
OpenAlexW4388816664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.